Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 30, 2023
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
Ben Hendrix Maintained (CHE) at Buy with Increased Target to $604 on, Oct 30th, 2023
Ben Hendrix of RBC Capital, Maintained "Chemed Corporation" (CHE) at Buy with Increased Target from $576 to $604 on, Oct 30th, 2023.
Ben has made no other calls on CHE in the last 4 months.
There is 1 other peer that has a rating on CHE. Out of the 1 peers that are also analyzing CHE, 0 agree with Ben's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ben
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $590 on, Thursday, July 27th, 2023
